• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基黄嘌呤与髓过氧化物酶的相互作用。一种抗炎机制。

Interaction of methyl-xanthines with myeloperoxidase. An anti-inflammatory mechanism.

作者信息

van Zyl J M, Kriegler A, van der Walt B J

机构信息

Department of Pharmacology, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.

出版信息

Int J Biochem. 1992 Jun;24(6):929-35. doi: 10.1016/0020-711x(92)90099-m.

DOI:10.1016/0020-711x(92)90099-m
PMID:1319356
Abstract
  1. Inhibition of myeloperoxidase (MPO)-catalyzed reactions by methyl-substituted xanthines has been investigated. 2. Except for theobromine and caffeine, all xanthines tested were potent inhibitors of the MPO-H2O2-Cl- system. 3. In contrast to methyl substitution in the 1 or 8 position of xanthine, substitution in the 3 or 7 position had a marked effect on the inhibition of MPO catalysis. 4. Two different inhibitory mechanisms were induced; scavenging of hypochlorous acid (HOCl) generated by the MPO system and accumulation of Compound II (ferryl MPO) which is inactive as a catalyst of Cl- oxidation.
摘要
  1. 已对甲基取代的黄嘌呤对髓过氧化物酶(MPO)催化反应的抑制作用进行了研究。2. 除了可可碱和咖啡因外,所有测试的黄嘌呤都是MPO-H2O2-Cl-系统的强效抑制剂。3. 与黄嘌呤1位或8位的甲基取代不同,3位或7位的取代对MPO催化的抑制有显著影响。4. 诱导了两种不同的抑制机制;清除MPO系统产生的次氯酸(HOCl)和积累作为Cl-氧化催化剂无活性的化合物II(高铁MPO)。

相似文献

1
Interaction of methyl-xanthines with myeloperoxidase. An anti-inflammatory mechanism.甲基黄嘌呤与髓过氧化物酶的相互作用。一种抗炎机制。
Int J Biochem. 1992 Jun;24(6):929-35. doi: 10.1016/0020-711x(92)90099-m.
2
Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.氯法齐明和氨苯砜抑制髓过氧化物酶系统的机制。与其抗炎特性的可能关联。
Biochem Pharmacol. 1991 Jul 15;42(3):599-608. doi: 10.1016/0006-2952(91)90323-w.
3
Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.抗氧化非甾体抗炎药对髓过氧化物酶和次氯酸鲁米诺增强化学发光作用的比较。
Agents Actions. 1982 Apr;12(1-2):232-8. doi: 10.1007/BF01965152.
4
Inhibition of the myeloperoxidase-H2O2-Cl- system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs.吲哚美辛及其他非甾体抗炎药对中性粒细胞髓过氧化物酶-H2O2-Cl-系统的抑制作用
Biochem Pharmacol. 1991;41(6-7):975-84. doi: 10.1016/0006-2952(91)90204-i.
5
Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.非甾体抗炎药对髓过氧化物酶氯化活性的抑制作用:氟芬那酸及其5-氯衍生物直接与重组人髓过氧化物酶相互作用以抑制次氯酸的合成。
Eur J Pharmacol. 2007 Sep 10;570(1-3):235-43. doi: 10.1016/j.ejphar.2007.05.057. Epub 2007 Jun 12.
6
Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.抗炎药物抑制髓过氧化物酶的机制。
Biochem Pharmacol. 1991 May 15;41(10):1485-92. doi: 10.1016/0006-2952(91)90565-m.
7
Inhibition of peroxidase-catalyzed reactions by deferoxamine.去铁胺对过氧化物酶催化反应的抑制作用。
Arch Biochem Biophys. 1988 Aug 1;264(2):600-6. doi: 10.1016/0003-9861(88)90326-8.
8
Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme.用重组人酶研究非甾体抗炎药对髓过氧化物酶氯化活性的抑制作用。
Eur J Pharmacol. 2001 Apr 6;417(1-2):37-43. doi: 10.1016/s0014-2999(01)00895-0.
9
Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.褪黑素可防止髓过氧化物酶血红素的破坏以及由自身产生的次氯酸介导的游离铁的生成。
PLoS One. 2015 Apr 2;10(3):e0120737. doi: 10.1371/journal.pone.0120737. eCollection 2015.
10
Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid.
Braz J Med Biol Res. 2005 Nov;38(11):1575-83. doi: 10.1590/s0100-879x2005001100003. Epub 2005 Oct 26.